Ridgeline overview
Ridgeline contact information
Offices
1350 Concourse Ave, Suite 364, Memphis, 38104, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Ryan Clinton | Job titleFounder and Managing Partner | LocationMemphis, United States | Email  ------ |
| Mr. Andrew McMahon | Job titleCo Founder and General Partner | LocationMemphis, United States | Email ----------- |
| Mr. Ben Walker | Job titleGeneral Partner | LocationMemphis, United States | Email ------ |
| Ms. Kristin (Cade) Carlson | Job titleAsset Manager | LocationMemphis, United States | Email -------- |
Ridgeline funds managed
Closed funds: 1
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size --------- | Close dateOct 2022 | Strategy ---------- | |
Stories that mention Ridgeline
AI firm Neural Magic scores $30m Series A
Neural Magic, an AI company, has raised $30 million in Series A funding.
Replicated collects $50m Series C
Replicated, which enables software vendors to operationalize and scale the delivery of their applications into complex enterprise multi-prem environments, has raised $50 million in Series C funding.
Industrial data startup MachineMetrics rallies $20m Series B
MachineMetrics, an industrial data startup, has raised $20 million in Series B financing.
Satellite Vu procures $5m seed
Satellite Vu, a provider of miniaturized satellites, has secured $5 million in seed funding.
Versant Ventures expands team and promotes staffers
Versant Ventures has made multiple promotions and appointments.
Black Diamond to set up shop in Toronto with $20 mln round
Black Diamond Therapeutics, a Stony Brook, New York-based cancer precision medicine platform, has emerged from stealth with a $20 million Series A financing. The round was backed by life sciences venture capital firm Versant Ventures. The company will use a share of the proceeds to set up operations in Toronto, giving it access to the city’s pool of computing talent. Black Diamond, the first startup launched out of Versant’s Swiss discovery engine, is developing precision medicines directed against allosteric mutant oncogenes.
Black Diamond to set up shop in Toronto with $20 mln round
Black Diamond Therapeutics, a Stony Brook, New York-based cancer precision medicine platform, has emerged from stealth with a US$20 million Series A financing. The round was backed by U.S. life sciences venture capital firm Versant Ventures. The company will use a share of the proceeds to set up operations in Toronto, giving it access to the city’s pool of computing talent. Black Diamond, the first startup launched out of Versant's Swiss discovery engine, is developing precision medicines directed against allosteric mutant oncogenes.
Who went where
A comprensive list of general partners and other VC professionals who changed jobs in the last 12 months